4//SEC Filing
Stankovic Srdjan R. 4
Accession 0001209191-22-002749
CIK 0001070494other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 6:23 PM ET
Size
8.8 KB
Accession
0001209191-22-002749
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2022-01-06+5,444→ 46,956 total - Sale
Common Stock
2022-01-06$23.05/sh−1,937$44,648→ 45,019 total - Exercise/Conversion
Restricted Stock Units
2022-01-06−5,444→ 10,889 total→ Common Stock (5,444 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning January 6, 2021.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001432545
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 6:23 PM ET
- Size
- 8.8 KB